Even worse, allogeneic hematopoietic stem cell transplantation (allo-HSCT) with HLA-matched related or unrelated donors has failed to improve the outcome of ALL cases with MLL-AF4 [7,9,10]. Here, KMT2A is linked to acute lymphoblastic leukemia.